Literature DB >> 29306991

Asthma and Medicines - Long-Term Side-Effects, Monitoring and Dose Titration.

Satnam Kaur1, Varinder Singh2.   

Abstract

Asthma is a major pediatric respiratory morbidity requiring long-term management. A thorough knowledge of long-term medication side-effects in children is, thus, essential for every physician dealing with childhood asthma. Establishing diagnosis and initiating treatment is just a beginning of the journey. Ongoing monitoring is an essential component of comprehensive asthma management programme. Monitoring includes not only assessment of asthma control but also checking for adherence to treatment, technique of inhaler device use, associated co-morbities, if any, and potential environmental exposure. Various tools - both subjective and objective - are available for assessment of asthma control. However, evidence for their optimum use in different settings and patient groups is lacking and monitoring has to be customized depending on available resources and individual patient characteristics. Patient education is an important component of long-term asthma therapy. The ultimate aim is to achieve optimum asthma control i.e., achieve and maintain control of clinical symptoms, decrease future risk to patients (risk of exacerbations, progressive loss of lung function and development of fixed airflow obstruction, adverse effects of medications) and enabling the child to lead a life without restrictions, at lowest possible dose of drugs. This article reviews the side-effects of medications used for long-term management of asthma and discusses current literature on asthma monitoring and dose titration in pediatric population to help the asthma therapist not only prescribe the drugs rationally but also help the family make right choices for treatment.

Entities:  

Keywords:  Childhood asthma; Dose titration; Management; Monitoring; Side-effects; Step-down

Mesh:

Substances:

Year:  2018        PMID: 29306991     DOI: 10.1007/s12098-017-2553-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  56 in total

1.  Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood.

Authors:  Rachel I Gafni; Jeffrey Baron
Journal:  Pediatrics       Date:  2007-03       Impact factor: 7.124

Review 2.  Influence of comorbid conditions on asthma.

Authors:  L-P Boulet
Journal:  Eur Respir J       Date:  2009-04       Impact factor: 16.671

3.  Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review.

Authors:  K D Kelly; C H Spooner; B H Rowe
Journal:  Eur Respir J       Date:  2001-01       Impact factor: 16.671

Review 4.  Monitoring asthma in children.

Authors:  Mariëlle W Pijnenburg; Eugenio Baraldi; Paul L P Brand; Kai-Håkon Carlsen; Ernst Eber; Thomas Frischer; Gunilla Hedlin; Neeta Kulkarni; Christiane Lex; Mika J Mäkelä; Eva Mantzouranis; Alexander Moeller; Ian Pavord; Giorgio Piacentini; David Price; Bart L Rottier; Sejal Saglani; Peter D Sly; Stanley J Szefler; Thomy Tonia; Steve Turner; Edwina Wooler; Karin C Lødrup Carlsen
Journal:  Eur Respir J       Date:  2015-03-05       Impact factor: 16.671

5.  Inhaled corticosteroids in children with persistent asthma: effects on growth.

Authors:  Linjie Zhang; Sílvio O M Prietsch; Francine M Ducharme
Journal:  Evid Based Child Health       Date:  2014-12

6.  Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands.

Authors:  T W de Vries; J J de Langen-Wouterse; E van Puijenbroek; E J Duiverman; L T W de Jong-Van den Berg
Journal:  Eur J Clin Pharmacol       Date:  2006-04-01       Impact factor: 2.953

Review 7.  Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.

Authors:  Hans Bisgaard; David Skoner; Maria L Boza; Carol A Tozzi; Kathleen Newcomb; Theodore F Reiss; Barbara Knorr; Gertrude Noonan
Journal:  Pediatr Pulmonol       Date:  2009-06

Review 8.  Nedocromil sodium for chronic asthma in children.

Authors:  A V Sridhar; M McKean
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

9.  CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma.

Authors:  Karine Issa-El-Khoury; Harold Kim; Edmond S Chan; Tim Vander Leek; Francisco Noya
Journal:  Allergy Asthma Clin Immunol       Date:  2015-03-14       Impact factor: 3.406

Review 10.  FeNO and asthma treatment in children: a systematic review and meta-analysis.

Authors:  Min Lu; Beirong Wu; Datian Che; Rong Qiao; Haoxiang Gu
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

View more
  2 in total

1.  Advances in Management of Asthma.

Authors:  Umakanth Katwa; S K Kabra
Journal:  Indian J Pediatr       Date:  2018-07-28       Impact factor: 1.967

Review 2.  Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.

Authors:  Amelia Licari; Ilaria Brambilla; Alessia Marseglia; Maria De Filippo; Valeria Paganelli; Gian L Marseglia
Journal:  Front Pediatr       Date:  2018-06-19       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.